Literature DB >> 21279816

Ribosome defects in disorders of erythropoiesis.

Anupama Narla1,2,3, Slater N Hurst2, Benjamin L Ebert4,5,6.   

Abstract

Over the past decade, genetic lesions that cause ribosome dysfunction have been identified in both congenital and acquired human disorders. These discoveries have established a new category of disorders, known as ribosomopathies, in which the primary pathophysiology is related to impaired ribosome function. The protoptypical disorders are Diamond-Blackfan anemia, a congenital bone marrow failure syndrome, and the 5q- syndrome, a subtype of myelodysplastic syndrome. In both of these disorders, impaired ribosome function causes a severe macrocytic anemia. In this review, we will discuss the evidence that defects in ribosomal biogenesis cause the hematologic phenotype of Diamond-Blackfan anemia and the 5q- syndrome. We will also explore the potential mechanisms by which a ribosomal defect, which would be expected to have widespread consequences, may lead to specific defects in erythropoiesis.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21279816      PMCID: PMC3689295          DOI: 10.1007/s12185-011-0776-0

Source DB:  PubMed          Journal:  Int J Hematol        ISSN: 0925-5710            Impact factor:   2.490


  50 in total

1.  A kinetic model of the erythron.

Authors:  L G LAJTHA; R OLIVER
Journal:  Proc R Soc Med       Date:  1961-05

2.  Extraribosomal functions of ribosomal proteins.

Authors:  I G Wool
Journal:  Trends Biochem Sci       Date:  1996-05       Impact factor: 13.807

3.  Distinct haematological disorder with deletion of long arm of no. 5 chromosome.

Authors:  H Van den Berghe; J J Cassiman; G David; J P Fryns; J L Michaux; G Sokal
Journal:  Nature       Date:  1974-10-04       Impact factor: 49.962

4.  Deficiency of ribosomal protein S19 in CD34+ cells generated by siRNA blocks erythroid development and mimics defects seen in Diamond-Blackfan anemia.

Authors:  Johan Flygare; Thomas Kiefer; Koichi Miyake; Taiju Utsugisawa; Isao Hamaguchi; Lydie Da Costa; Johan Richter; Edward J Davey; Hans Matsson; Niklas Dahl; Maciej Wiznerowicz; Didier Trono; Stefan Karlsson
Journal:  Blood       Date:  2004-12-30       Impact factor: 22.113

5.  An RNA interference model of RPS19 deficiency in Diamond-Blackfan anemia recapitulates defective hematopoiesis and rescue by dexamethasone: identification of dexamethasone-responsive genes by microarray.

Authors:  Benjamin L Ebert; Michele M Lee; Jennifer L Pretz; Aravind Subramanian; Raymond Mak; Todd R Golub; Colin A Sieff
Journal:  Blood       Date:  2005-03-08       Impact factor: 22.113

6.  Ribosomal protein L23 activates p53 by inhibiting MDM2 function in response to ribosomal perturbation but not to translation inhibition.

Authors:  Mu-Shui Dai; Shelya X Zeng; Yetao Jin; Xiao-Xin Sun; Larry David; Hua Lu
Journal:  Mol Cell Biol       Date:  2004-09       Impact factor: 4.272

7.  Positional cloning of a gene involved in the pathogenesis of Treacher Collins syndrome. The Treacher Collins Syndrome Collaborative Group.

Authors: 
Journal:  Nat Genet       Date:  1996-02       Impact factor: 38.330

8.  Inhibition of MDM2-mediated p53 ubiquitination and degradation by ribosomal protein L5.

Authors:  Mu-Shui Dai; Hua Lu
Journal:  J Biol Chem       Date:  2004-08-11       Impact factor: 5.157

9.  Ribosomal protein L11 negatively regulates oncoprotein MDM2 and mediates a p53-dependent ribosomal-stress checkpoint pathway.

Authors:  Yanping Zhang; Gabrielle White Wolf; Krishna Bhat; Aiwen Jin; Theresa Allio; William A Burkhart; Yue Xiong
Journal:  Mol Cell Biol       Date:  2003-12       Impact factor: 4.272

10.  The gene encoding ribosomal protein S19 is mutated in Diamond-Blackfan anaemia.

Authors:  N Draptchinskaia; P Gustavsson; B Andersson; M Pettersson; T N Willig; I Dianzani; S Ball; G Tchernia; J Klar; H Matsson; D Tentler; N Mohandas; B Carlsson; N Dahl
Journal:  Nat Genet       Date:  1999-02       Impact factor: 38.330

View more
  21 in total

1.  Ribonuclease inhibitor 1 regulates erythropoiesis by controlling GATA1 translation.

Authors:  Vijaykumar Chennupati; Diogo Ft Veiga; Kendle M Maslowski; Nicola Andina; Aubry Tardivel; Eric Chi-Wang Yu; Martina Stilinovic; Cedric Simillion; Michel A Duchosal; Manfredo Quadroni; Irene Roberts; Vijay G Sankaran; H Robson MacDonald; Nicolas Fasel; Anne Angelillo-Scherrer; Pascal Schneider; Trang Hoang; Ramanjaneyulu Allam
Journal:  J Clin Invest       Date:  2018-03-19       Impact factor: 14.808

2.  Single-cell analyses demonstrate that a heme-GATA1 feedback loop regulates red cell differentiation.

Authors:  Raymond T Doty; Xiaowei Yan; Christopher Lausted; Adam D Munday; Zhantao Yang; Danielle Yi; Neda Jabbari; Li Liu; Siobán B Keel; Qiang Tian; Janis L Abkowitz
Journal:  Blood       Date:  2018-12-10       Impact factor: 22.113

3.  MYSM1 maintains ribosomal protein gene expression in hematopoietic stem cells to prevent hematopoietic dysfunction.

Authors:  Jad I Belle; HanChen Wang; Amanda Fiore; Jessica C Petrov; Yun Hsiao Lin; Chu-Han Feng; Thi Tuyet Mai Nguyen; Jacky Tung; Philippe M Campeau; Uta Behrends; Theresa Brunet; Gloria Sarah Leszinski; Philippe Gros; David Langlais; Anastasia Nijnik
Journal:  JCI Insight       Date:  2020-07-09

4.  Bmi1 promotes erythroid development through regulating ribosome biogenesis.

Authors:  Rui Gao; Sisi Chen; Michihiro Kobayashi; Hao Yu; Yingchi Zhang; Yang Wan; Sara K Young; Anthony Soltis; Ming Yu; Sasidhar Vemula; Ernest Fraenkel; Alan Cantor; Yevgeniy Antipin; Yang Xu; Mervin C Yoder; Ronald C Wek; Steven R Ellis; Reuben Kapur; Xiaofan Zhu; Yan Liu
Journal:  Stem Cells       Date:  2015-03       Impact factor: 6.277

Review 5.  Regulatory Roles of Rpl22 in Hematopoiesis: An Old Dog with New Tricks.

Authors:  Shawn P Fahl; Minshi Wang; Yong Zhang; Anne-Cecile E Duc; David L Wiest
Journal:  Crit Rev Immunol       Date:  2015       Impact factor: 2.214

Review 6.  Translational control in cancer etiology.

Authors:  Davide Ruggero
Journal:  Cold Spring Harb Perspect Biol       Date:  2013-02-01       Impact factor: 10.005

Review 7.  The cancerous translation apparatus.

Authors:  Craig R Stumpf; Davide Ruggero
Journal:  Curr Opin Genet Dev       Date:  2011-05-03       Impact factor: 5.578

8.  Using induced human pluripotent stem cells to study Diamond-Blackfan anemia: an outlook on the clinical possibilities.

Authors:  Philip J Mason; Nieves Perdigones; Monica Bessler
Journal:  Expert Rev Hematol       Date:  2013-12       Impact factor: 2.929

9.  MMP9 inhibition increases erythropoiesis in RPS14-deficient del(5q) MDS models through suppression of TGF-β pathways.

Authors:  Minyoung Youn; Haigen Huang; Cheng Chen; Sharon Kam; Mark C Wilkes; Hee-Don Chae; Kunju J Sridhar; Peter L Greenberg; Bertil Glader; Anupama Narla; Shuo Lin; Kathleen M Sakamoto
Journal:  Blood Adv       Date:  2019-09-24

10.  Replication stress is a potent driver of functional decline in ageing haematopoietic stem cells.

Authors:  Johanna Flach; Sietske T Bakker; Mary Mohrin; Pauline C Conroy; Eric M Pietras; Damien Reynaud; Silvia Alvarez; Morgan E Diolaiti; Fernando Ugarte; E Camilla Forsberg; Michelle M Le Beau; Bradley A Stohr; Juan Méndez; Ciaran G Morrison; Emmanuelle Passegué
Journal:  Nature       Date:  2014-07-30       Impact factor: 49.962

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.